Endoscopic removal for small rectal tumors
Part of Cancer, Digestive system clinical trials.
This trial studies two ways to remove small rectal neuroendocrine tumors (slow-growing tumors in the rectum) using an endoscope. It aims to see which method works better and if it can be done safely and effectively without more invasive surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 80 years old.
- You must have a small rectal tumor (10 mm or smaller) that a doctor suspects is a neuroendocrine tumor.
- You must be planning to have the tumor removed with a special endoscope procedure (called mEMR-C or mEMR-L).
- You cannot have cancer that has spread to lymph nodes or other organs.
- You cannot have had a previous surgery for this same tumor, and you cannot have more than one of these tumors in the rectum.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing whether a minimally invasive endoscopic procedure (using a scope through the anus) can safely remove small rectal neuroendocrine tumors. If you're eligible, this could be a less invasive way to treat your condition without major surgery.
This study compares two minimally invasive ways to remove small rectal neuroendocrine tumors (NETs), which are growths in the rectum that are usually not cancer. The goal is to find which method is safer and more effective with fewer side effects.
This trial tests whether using a special traction device during endoscopic removal of small rectal neuroendocrine tumors is safer or more effective than the standard method. It may help patients with these tumors have a less invasive treatment.
This study compares two ways of removing very small rectal neuroendocrine tumors (less than 1 cm): a modified technique using a special snare (mDS-EMR) versus a more involved removal called ESD. Both are done through a scope (endoscopy) without major surgery.
This study compares two minimally invasive endoscopic techniques—ESD and EPMR—for removing small neuroendocrine tumors (slow-growing hormone-producing tumors) in the rectum. The goal is to see which approach works better and is safer for patients.
This trial tests a new robotic system to remove large, flat growths in the lower part of the rectum that are too big for standard removal. The goal is to remove the growth completely in one piece, which may help avoid more invasive surgery.
Hear when a new Rectal Neuroendocrine Tumor trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.